Decision Aid (DA) for Renal Patients

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT05387863
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Decision Aid (DA) Web Tool — OTHER
    The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.
  • Institutional Pamphlet — OTHER
    The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.

Study Details

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Key Dates

Start date
Sep 12, 2022
Status verified
Nov 2025
Primary completion
Jun 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Decision Aid (DA) Web Tool
  • Active Comparator: Institutional Pamphlet

Primary Outcome Measure

Knowledge Score [ Time Frame: Pre-Counsel, 1 day Visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016
Stella Kang, MD
[email protected]
Samantha Sanger
[email protected]
Stella Kang, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By condition
Kidney cancer
By specialty
OncologyUrology
By research site
NYU Langone Health· New York, NY

Related Studies